Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bile acid transporter proteins are a group of membrane transporters essential for the enterohepatic circulation and homeostasis of bile acids. They mediate the uptake, transcellular movement, and efflux of bile acids across cellular membranes in the liver, intestine, kidney, and other tissues. Key examples include NTCP (SLC10A1), ASBT/IBAT (SLC10A2), and OSTalpha/OSTbeta (SLC51A/SLC51B). These transporters are involved in the reabsorption of bile acids from the intestine back to the liver, as well as the uptake of bile acids from the blood into the liver. Genetic deficiencies and drug interactions targeting these transporters can have significant clinical consequences.
Inhibition of bile acid transport
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bile Acid Transporter Protein.